Atkinson William
Biotechnol Healthc. 2007 Apr;4(2):24-30.
Is 'coverage with evidence development' a happy medium between 'no evidence, no coverage,' and the sky-high promise of some new biologic therapies, diagnostics, and devices? Medicare plans to find out. The application of CED raises a number of questions, the answers to which may determine whether it is a suitable model for private payers trying to answer the value equation.